TheEdgeResearch
Home / Stocks / CMLF

CM Life Sciences, Inc. (CMLF)

NASDAQ Financial Services Shell Companies
$11.60 ▼ -7.05%
Market Cap
$0
Sector
Financial Services
Industry
Shell Companies
Beta
0.00
52-Wk Range
11.4-12.43
CEO
Eli Decatur Casdin
Country
US
Currency
USD

CM Life Sciences, Inc. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $11.60, down 7.05% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of -3.14, a net margin of -23.4%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.14
Price / Sales
0.00
Price / Book
1.41
EV / EBITDA
-1.05
Gross margin
69.4%
Operating margin
-20.3%
Net margin
-23.4%
Return on equity
Debt / equity
0.29
Current ratio
3.30
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
IPO date
2020-10-26
Headquarters
New York City, NY, US
About CM Life Sciences, Inc.

CM Life Sciences, Inc. is dedicated to completing a business combination, which may involve various strategic transactions such as a merger, an asset or stock acquisition, a capital stock exchange, or a corporate reorganization, with one or more entities. This New York-based firm commenced operations in 2020.

Comparable companies

CM Life Sciences, Inc. is most often compared with the following Financial Services names:

AACACQRBCACCMIIDFLIFSNBMITMSDA
More research on CMLF
CMLF technical analysis CMLF TheEdge Score Compare against peers
Open full interactive analysis & DCF →